Synthetic Psychedelics
MDMA
The most effective empathogen ever discovered. FDA Breakthrough Therapy designation for PTSD. Used therapeutically, recreationally, and spiritually by millions of people worldwide. Also one of the most adulterated substances on the market — which means testing isn't optional, it's survival.
The Basics
What MDMA actually does
MDMA floods your brain with serotonin, dopamine, and norepinephrine simultaneously. The result is a unique state: deep emotional openness, empathy for yourself and others, physical euphoria, reduced fear response, and a sense that everything difficult in your life is approachable and workable. There's a reason therapists were using it before it was scheduled — it makes psychological material that's normally defended against feel safe to engage with.
Recreationally, MDMA produces intense euphoria, desire for social connection, heightened sensory experience (especially touch and music), and energy. The experience typically peaks for 2–3 hours with a gentle comedown. The distinction between therapeutic and recreational use is often artificial — many people have their most meaningful psychological insights at a concert.
⚠ Adulteration is the primary risk
Most MDMA-related deaths and hospitalizations involve substances that aren't MDMA — fentanyl, methamphetamine, bath salts (synthetic cathinones), PMA/PMMA, or unknown research chemicals. Testing is not paranoia, it's the single most important harm reduction step. Marquis reagent (dark purple/black = MDxx), Mecke (dark blue/black), and Simon's (blue = MDMA, no reaction = MDA) is the minimum kit. Fentanyl test strips are an additional must.
The Science
Serotonin release — the mechanism and the cost
Triple monoamine release
MDMA reverses serotonin, dopamine, and norepinephrine transporters, flooding synapses. Serotonin release is the dominant action and produces the empathogenic effects. Dopamine contributes euphoria. Norepinephrine drives stimulation and temperature regulation issues.
Oxytocin release
MDMA triggers significant oxytocin release — the "bonding hormone." This is likely a major contributor to the feelings of trust, closeness, and empathy that distinguish MDMA from pure stimulants.
Neurotoxicity
MDMA's serotonergic neurotoxicity is real but dose-dependent and frequency-dependent. Moderate, infrequent use (≤120mg, ≥3 months apart) carries substantially lower risk than high-dose, frequent use. The damage is to serotonin axon terminals — which can regenerate, but slowly.
Therapeutic research
MAPS (now Lykos Therapeutics) completed Phase 3 clinical trials for MDMA-assisted therapy for PTSD. The FDA initially denied approval in 2024 citing study design concerns, but the clinical data showed significant efficacy. The therapeutic landscape continues to evolve.
Dosing Guide
Less is more — seriously
The clinical trial dose for PTSD therapy is 80–120mg. Most people using MDMA recreationally take too much. Higher doses don't produce more empathy or connection — they produce more stimulation, more jaw clenching, more temperature dysregulation, and more neurotoxicity. The most cited range in harm reduction literature is lower than most people think.
Threshold / Therapeutic
75–100mg
Emotional warmth, mild euphoria, openness, reduced anxiety. The therapeutic range. Enough to shift your emotional state significantly without overwhelming stimulation. Many experienced users prefer this range.
Common / Recreational
100–125mg
Full MDMA experience. Strong empathy, euphoria, desire for connection, sensory enhancement. Physical effects — jaw tension, dilated pupils, mild nausea on come-up. This is the range most clinical trials use.
High
150mg+
Diminishing emotional returns, increasing physical side effects. More stimulation, more jaw tension, more temperature issues, significantly more neurotoxicity. The empathogenic quality actually decreases as the stimulant quality takes over. Not recommended.
⚠ Redosing
A single redose of 50–75% of the original dose, taken 90 minutes in, extends the experience by 1–2 hours. This is common practice. Multiple redoses don't work well — you get diminishing returns, increasing side effects, and disproportionate neurotoxicity. Your serotonin stores are already depleted after the first release. You can't release what isn't there.
Harm Reduction
The things that actually save lives
Test every batch. Every time. Reagent kits + fentanyl strips. This is the single most important harm reduction practice for MDMA. It is not negotiable.
Three-month rule. Minimum 3 months between uses to allow serotonin system recovery. This isn't conservative advice — it's the floor for responsible use.
Hydrate sensibly. Drink water, but not excessively. Hyponatremia (water intoxication) has killed MDMA users — usually women, usually at events. Sip, don't chug. Electrolyte drinks are better than plain water.
Temperature management. MDMA impairs thermoregulation. Hot environments + dancing + MDMA = hyperthermia risk. Take breaks. Cool down. If someone is hot, confused, and stopped sweating — that's a medical emergency.
SSRIs make MDMA not work. If you're on an SSRI, MDMA will either not work or work poorly. Do not stop your SSRI to take MDMA without medical guidance. Do not take more MDMA because it's not working — you'll get side effects without the desired experience.
MAOIs are genuinely dangerous with MDMA. Serotonin syndrome risk is high. This includes ayahuasca. If you've consumed any MAO inhibitor in the past two weeks, do not take MDMA.
The comedown is normal. Depleted serotonin = 1–3 days of reduced mood, sometimes called "suicide Tuesday." It passes. 5-HTP supplementation starting 24 hours after (not during) can help. If the comedown doesn't resolve within a week, that warrants attention.
Cardiovascular considerations. MDMA raises heart rate, blood pressure, and body temperature simultaneously. Pre-existing hypertension, arrhythmias, structural heart disease, or any condition that compromises temperature regulation is a contraindication. The cardiovascular load is one of the substance's primary acute risks.
Pregnancy and conception. Pregnancy is a hard contraindication. Hyperthermia, hypertension, and serotonergic effects all compound prenatal risk. Breastfeeding is also a contraindication. Same applies if you're actively trying to conceive.
Tramadol. Tramadol is a serotonin-norepinephrine reuptake inhibitor in addition to being an opioid. Combined with MDMA the risk of serotonin syndrome and seizure is significant — multiple deaths are documented. The combination is widely under-recognized because tramadol is prescribed casually for pain. If you've taken tramadol within the last 24 hours, don't take MDMA.
Tim's Take
I haven't used MDMA. My honest take is shaped by the pharmacology, the research history, and watching the FDA rejection of Lykos Therapeutics in 2024 play out.
MDMA is not a classical psychedelic in the way LSD or psilocybin are. It's an entactogen. It floods your brain with serotonin and norepinephrine in a way that produces empathy, emotional openness, and a specific therapeutic window that the research has demonstrated is real for PTSD. That's not in question. What is in question is the supply chain, the dose, and what else is in the pill. Street MDMA is frequently not MDMA at all, or it's cut with meth, bath salts, PMA, or whatever else was cheap that week. Testing matters. Reagent kits matter.
The cardiac risk gets undersold. MDMA raises blood pressure and heart rate directly through norepinephrine release. The racing heart and spiking blood pressure on MDMA isn't a symptom of a bad trip. That's the drug. If you have an undiagnosed cardiac issue, MDMA is the substance most likely to find it. There's also long term concern about the 5-HT2B receptor and heart valve effects with heavy use, through the same mechanism that got the diet drug fen-phen pulled from the market in the 90s.
I'm not against MDMA. I think the therapeutic case for it is genuine and the FDA rejection had as much to do with trial methodology and data integrity issues as with the substance itself. But recreationally, in the current supply environment, the risk profile is stacked against you unless you're testing your material and spacing your sessions out by months, not weekends.
If you or someone you know needs support
The Fireside Project provides free emotional support during or after a psychedelic experience. Available by call or text, 24 hours a day.
Call or text · Available 24/7 · Free · Non-judgmental
Know Before You Go
Based on documented risks and harm reduction literature, practitioners typically advise the following.
Test every batch. Fentanyl, meth, and bath salts are commonly sold as MDMA. Reagent kits + fentanyl strips.
Three-month minimum between uses. Neurotoxicity is dose and frequency dependent.
Less is more. 100–125mg is a commonly cited range in harm reduction literature. Higher doses correlate with more side effects, not more empathy.
Hydrate sensibly. Sip, don't chug. Hyponatremia kills. Electrolytes > plain water.
If someone is hot and stopped sweating, that's a medical emergency. Call 911.
Fireside Project: 623-473-7433. Save it before you need it.
Last reviewed